Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Clinical Lung Cancer
|
August 8, 2017
Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments
Jon Zugazagoitia, Daniel Rueda, Nuria Carrizo, et al.
European Journal of Human Genetics : EJHG
|
January 28, 2024
A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells
Zain Awamleh, Sanaa Choufani, Wendy Wu, et al.
Stem Cell Reports
|
May 2, 2017
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
Jorge Gómez-Miragaya, Marta Palafox, Laia Paré, et al.
Oncoimmunology
|
August 29, 2024
CD4<sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
Anaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2021
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB<sup>2</sup> harmonization project comparing three NGS panels
Javier Ramos-Paradas, Susana Hernández-Prieto, David Lora, et al.
Cancer Research
|
July 25, 2025
Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
Esther Redin, Nerea Otegui, Mirentxu Santos, et al.
The Journal of Clinical Investigation
|
November 1, 2019
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma
Emilie Bousquet Mur, Sara Bernardo, Laura Papon, et al.
EMBO Molecular Medicine
|
November 11, 2025
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations
Irene Ballesteros-González, Iván Hernández-Navas, Oksana Brehey, et al.
Nature Communications
|
June 27, 2024
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies
Sarah Figarol, Célia Delahaye, Rémi Gence, et al.
Clinical and Translational Medicine
|
July 17, 2025
Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion
Cristina Cirauqui, Laura Ojeda, Itziar Otano, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Clinical Lung Cancer
|
August 8, 2017
Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments
Jon Zugazagoitia, Daniel Rueda, Nuria Carrizo, et al.
European Journal of Human Genetics : EJHG
|
January 28, 2024
A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells
Zain Awamleh, Sanaa Choufani, Wendy Wu, et al.
Stem Cell Reports
|
May 2, 2017
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
Jorge Gómez-Miragaya, Marta Palafox, Laia Paré, et al.
Oncoimmunology
|
August 29, 2024
CD4<sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
Anaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2021
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB<sup>2</sup> harmonization project comparing three NGS panels
Javier Ramos-Paradas, Susana Hernández-Prieto, David Lora, et al.
Cancer Research
|
July 25, 2025
Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
Esther Redin, Nerea Otegui, Mirentxu Santos, et al.
The Journal of Clinical Investigation
|
November 1, 2019
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma
Emilie Bousquet Mur, Sara Bernardo, Laura Papon, et al.
EMBO Molecular Medicine
|
November 11, 2025
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations
Irene Ballesteros-González, Iván Hernández-Navas, Oksana Brehey, et al.
Nature Communications
|
June 27, 2024
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies
Sarah Figarol, Célia Delahaye, Rémi Gence, et al.
Clinical and Translational Medicine
|
July 17, 2025
Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion
Cristina Cirauqui, Laura Ojeda, Itziar Otano, et al.
Page
of 7